In contrast, GBM exhibits low ADAR2 expression, leading to reduced editing of miR-589-3P, which then shifts its target to ADAM12, which encodes a metalloproteinase that drives GBM proliferation [99] (Figure 2D). Here, ADAM12 is linked to glioblastoma.